Bessemer Group Inc Meridian Bioscience Inc Transaction History

Bessemer Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$30.9 - $33.55 $927 - $1,006	-30 Reduced 18.87%	129 $4,000
Q1 2022 May 12, 2022	BUY	$19.97 - $26.94 $3,175 - $4,283	159 New	159 $4,000
Q3 2020 Nov 12, 2020	SELL	$13.54 - $26.41 $8,205 - $16,004	-606 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$7.84 - $23.29 $4,751 - $14,113	606 New	606 $14,000
Q1 2020 Apr 30, 2020	SELL	$5.57 - $11.5 $322,503 - $665,850	-57,900 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$7.9 - $10.14 $541,940 - $695,604	-68,600 Reduced 54.23%	57,900 $566,000
Q3 2019 Nov 07, 2019	BUY	$9.17 - $12.01 $647,402 - $847,906	70,600 Added 126.3%	126,500 $1.2 Million
Q2 2019 Jul 19, 2019	SELL	$10.88 - $17.6 $661,504 - $1.07 Million	-60,800 Reduced 52.1%	55,900 $664,000
Q1 2019 May 13, 2019	BUY	$15.51 - $17.61 $508,728 - $577,608	32,800 Added 39.09%	116,700 $2.06 Million
Q4 2018 Feb 12, 2019	BUY	$14.52 - $19.72 $291,852 - $396,372	20,100 Added 31.5%	83,900 $1.46 Million
Q1 2018 May 10, 2018	BUY	$13.8 - $16.2 $614,100 - $720,900	44,500 Added 230.57%	63,800 $906,000
Q4 2017 Jan 30, 2018	BUY	$13.55 - $15.8 $261,515 - $304,940	19,300	19,300 $270,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.